Search clinical trials for: ferric oxide, saccharated

Total 394 results

Vifor Pharma
Socar Research SA

Terminated

EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac Function in Patients With Iron deficiencY and Chronic Heart Failure (EFFICACY-HF)

Chronic Heart Failure | Iron Deficiency Anemia | Iron Deficiency | Anaemia

France, Netherlands, Denmark, Germany, Israel
Mark Frye
University of California, Los Angeles

Withdrawn

Can Additional Drug Therapy Accelerate Response Time to Antidepressants

Depression

United States
Vifor Pharma
Pierrel Research Europe GmbH

Completed

Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women (ASAP)

Anaemia

Australia, Germany, Sweden, Switzerland, Turkey
Centre Francois Baclesse
Roche Pharma AG; Hospira, now a wholly owned subsidiary of Pfizer; Vifor Pharma

Terminated

Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency

Solid Cancer Metastatic Disease | Lymphoid Disease

France
Zeria Pharmaceutical

Completed

Pharmacokinetics, Pharmacodynamics and Safety Study of Z-213 to Iron Deficiency Anemia

Iron Deficiency Anemia

Japan
Vifor Pharma
ICON Clinical Research

Completed

A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron Deficiency (CONFIRM-HF)

Chronic Heart Failure | Iron Deficiency

Poland, Russian Federation
Rockwell Medical Technologies, Inc.

Completed

Quantitative Mass Transfer of SFP-iron From Dialysate to Blood in CKD-HD Patients

Kidney Failure

United States
Rockwell Medical Technologies, Inc.

Completed

A Single Ascending Dose Study of Soluble Ferric Pyrophosphate Administered Intravenously in Healthy Volunteers.

Kidney Failure, Chronic Therapy; Hemodialysis

United States
Swiss Federal Institute of Technology

Completed

Iron Absorption From Rice Fortified With Ferric Pyrophosphate

Anemia | Iron Deficiency Anemia | Iron Deficiency

Switzerland
Keryx Biopharmaceuticals

Completed

A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis

Kidney Failure | Hyperphosphatemia

United States, Israel, Puerto Rico
Keryx Biopharmaceuticals

Completed

Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease

Hyperphosphatemia | End-stage Renal Disease | Renal Failure Chronic Requiring Hemodialysis

Israel
University of Zurich
Vifor Pharma

Completed

Restless Legs Syndrome With Iron Deficiency or Anaemia in the 3rd Trimester of Pregnancy

Iron Deficiency Anemia | Restless Leg Syndrome

Switzerland
Keryx Biopharmaceuticals
Collaborative Study Group (CSG)

Completed

A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease

End-Stage Renal Disease | Hyperphosphatemia

United States, Puerto Rico
Hospital Aleman
Vifor Pharma

Completed

Switch From Oral Iron to Intravenous Ferric Carboxymaltose in Non-dialysis Chronic Kidney Disease (CKD)

Iron Deficiency | Anaemia

Argentina
Instituto do Cancer do Estado de São Paulo
Fundação Faculdade de Medicina

Unknown

Iron Supplement in the Prevention of Anemia in Female Breast Cancer Patients

Breast Cancer

Brazil
Vifor Pharma
ICON Clinical Research; American Regent, Inc.

Completed

Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) (FIND-CKD)

Chronic Kidney Disease | Iron Deficiency Anaemia

United Kingdom, United States, Australia, Austria, Belgium, Czech Republic, Denmark, France, Germany, Greece, Italy, Netherlands, Norway, Poland, Portugal, Romania, Spain, Sweden, Turkey
Albion
Sprim Advanced Life Sciences

Unknown

A Study to Compare the Gastrointestinal Tolerability of Ferrochel®, Sumalate®,Ferrous Fumarate, Ferrous Sulfate, Ferric Glycinate, and Placebo

Anemia

Indonesia
Nottingham University Hospitals NHS Trust

Completed

Intravenous Iron: Measuring Response in Anemic Surgical Patients

Anemia | Colorectal Neoplasm

United Kingdom
Vifor Pharma

Completed

Ferric Carboxymaltose in Subjects With Functional Iron Deficiency Undergoing Chemotherapy (FID-CHEMO)

Iron-Deficiency Anemia

Germany, Sweden
Medical Research Council

Completed

A Pilot Study to Assess the Influence of Dietary Organic Acids on Iron Absorption.

Iron Deficiency Anaemia

United Kingdom
Pharmacosmos A/S

Completed

Open-label PK Study of Iron Isomaltoside 1000 (Monofer) Administered by 500 mg IV Injection or 1000 mg IV Infusion to Patients With Inflammatory Bowel Disease

Inflammatory Bowel Disease
Pharmacosmos A/S

Completed

Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous to Patients With CKD (PK-CKD-03)

Non-dialysis Dependent Chronic Kidney Disease
Swiss Federal Institute of Technology
Swiss National Science Foundation; Swiss Tropical & Public Health Institute

Completed

Efficacy of Iron Fortified Complementary Food and IPT of Malaria in Young Children in Côte d'Ivoire

Anemia

Côte D'Ivoire
University Hospital Muenster
Vifor Pharma

Terminated

Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery (PRIVIRON)

Anemia | Orthopedic Surgery | High Risk of Blood Loss

Germany
International Centre for Diarrhoeal Disease Research...
Nestlé Foundation; Nutrition Third World, Belgium

Completed

Ferrous Fumarate and Ferric Pyrophosphate as Food Fortificants in Developing Countries

Helicobacter Pylori Infection | Healthy Participants | Non-anemic Children
Watson Pharmaceuticals

Completed

2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.

Iron Deficiency Anemia

United States, Canada, Mexico, Bulgaria, India, Russian Federation, Croatia, Poland
Pharmacosmos A/S

Completed

Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia (CIA) (PK-CIA-04)

Non-hematological Malignancies
University of Zurich
Vifor Pharma

Terminated

Intravenous Ferric Carboxymaltose (Ferinject®) With or Without Erythropoietin in Patients Undergoing Orthopaedic Surgery

Iron Deficiency Anemia

Switzerland
University of Aarhus
Vifor Pharma; GCP-unit at Aarhus University Hospital, Aarhus, Denmark

Completed

Iron Substitution After Upper Gastro-Intestinal Bleeding

Anemia | Gastrointestinal Hemorrhage

Denmark
National Research Council, Spain
Ministry of Science and Innovation, Spain; Grupo Leche Pascual; Madrid Salud,...

Completed

Iron Fortified Beverages and Application in Women Predisposed to Anemia (FeDrink)

Iron-deficiency Anemia
Vifor Pharma
SGS S.A.

Completed

Ferric Carboxymaltose Treatment to Improve Fatigue Symptoms in Iron-deficient Non-anaemic Women of Child Bearing Age (Prefer)

Iron Deficiency

Austria
Watson Pharmaceuticals

Completed

Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients

Anemia

United States, Poland, Mexico, Serbia, Russian Federation
Watson Pharmaceuticals

Completed

Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents

Anemia, Iron-Deficiency | Kidney Failure, Chronic

United States, Puerto Rico
Watson Pharmaceuticals

Completed

Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients

Anemia, Iron-Deficiency | Kidney Failure, Chronic

United States, Puerto Rico
Watson Pharmaceuticals

Completed

Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy

Anemia

United States
Norwegian University of Science and Technology
St. Olavs Hospital; Sykehuset Innlandet HF; Sykehuset Buskerud HF

Terminated

Controlled Randomised Trial of Ferric Carboxymaltose and Oral Iron to Treat Postpartum Anemia

Anemia, Iron-Deficiency | Depression, Postpartum | Puerperal Disorders

Norway
Ain Shams University

Unknown

Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload

Sickle Cell Disease | Beta-thalassemia Major | Iron Hemosiderosis

Egypt
Enzon Pharmaceuticals, Inc.

Terminated

A Multicenter Study Evaluating the Safety and Tolerability of Intravenous rhMBL in Liver Transplant Recipients.

Liver Transplantation

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer

Lymphoma | Leukemia | Anemia | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Lymphoproliferative Disorder

United States
Amsterdam UMC, location VUmc
Vifor Pharma

Unknown

Iron Deficiency In Pulmonary Hypertension

Idiopathic Pulmonary Arterial Hypertension

Netherlands
Vifor Pharma

Terminated

Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD)

Thrombocytosis | Iron-Deficiency Anemia

Austria
Watson Pharmaceuticals

Completed

Study of the Safety and Efficacy of Ferrlecit® Maintenance Dosing in Pediatric Hemodialysis Patients

Anemia

United States
Quadram Institute Bioscience
The Coca-Cola Company

Completed

Relative Bioavailability of Ferric Pyrophosphate From an Apple Juice Drink

Iron Deficiency

United Kingdom
University of Toronto
The Hospital for Sick Children; Heinz Endowments

Completed

Relative Bioavailability of Iron and Folic Acid in New Test Supplement

Iron Deficiency | Folic Acid Deficiency

Canada

Search clinical trials for: ferric oxide, saccharated

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations